Document
IPR2024-00631, No. 1070 Exhibit - 1070 Boylan, Parenteral Products, in MODERN PHARMACEUTICS Gilbert S Banke (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1070 Exhibit - 1070 Boylan, Parenteral Products, in MODERN PHARMACEUTICS Gilbert S Banke (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1032 Exhibit - 1032 Knudsen, Glucagon like Peptide 1 The Basis of a New Class of Treatmen (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1032 Exhibit - 1032 Knudsen, Glucagon like Peptide 1 The Basis of a New Class of Treatmen (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1071 Exhibit - 1071 US Patent No 6,284,727 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1071 Exhibit - 1071 US Patent No 6,284,727 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1086 Exhibit - 1086 “Last Update Posted” definition from ClinicalTrialsgov httpsclinic (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1086 Exhibit - 1086 “Last Update Posted” definition from ClinicalTrialsgov httpsclinic (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1001 Exhibit - 1001 US Patent No 10,335,462 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1001 Exhibit - 1001 US Patent No 10,335,462 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1073 Exhibit - 1073 US Patent No 6,458,924 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1073 Exhibit - 1073 US Patent No 6,458,924 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1043 Exhibit - 1043 US Patent App Pub 20040102486 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1043 Exhibit - 1043 US Patent App Pub 20040102486 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1084 Exhibit - 1084 EMA, ICH Topic S 7 A Safety Pharmacology Studies for Human Pharmaceuti (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1084 Exhibit - 1084 EMA, ICH Topic S 7 A Safety Pharmacology Studies for Human Pharmaceuti (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1036 Exhibit - 1036 Mojsov, Insulinotropin Glucagon like Peptide I 7 37 Co encoded in t (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1036 Exhibit - 1036 Mojsov, Insulinotropin Glucagon like Peptide I 7 37 Co encoded in t (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1052 Exhibit - 1052 Madsbad, An Overview of Once Weekly Glucagon Like Peptide 1 Receptor A (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1052 Exhibit - 1052 Madsbad, An Overview of Once Weekly Glucagon Like Peptide 1 Receptor A (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1019 Exhibit - 1019 Bell, Hamster Preproglucagon Contains the Sequence of Glucagon and Two (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1019 Exhibit - 1019 Bell, Hamster Preproglucagon Contains the Sequence of Glucagon and Two (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1026 Exhibit - 1026 HARRISON’S PRINCIPLES OF INTERNAL MED, Chapter 338 Fauci et al eds (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1026 Exhibit - 1026 HARRISON’S PRINCIPLES OF INTERNAL MED, Chapter 338 Fauci et al eds (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1064 Exhibit - 1064 Monami, Effects of Glucagon Like Peptide 1 Receptor Agonists on Body W (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1064 Exhibit - 1064 Monami, Effects of Glucagon Like Peptide 1 Receptor Agonists on Body W (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1060 Exhibit - 1060 WO 2011058193 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1060 Exhibit - 1060 WO 2011058193 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1063 Exhibit - 1063 Kirillova, Results and Outcome Reporting in ClinicalTrialsgov, What M (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1063 Exhibit - 1063 Kirillova, Results and Outcome Reporting in ClinicalTrialsgov, What M (P.T.A.B. Mar. 1, 2024)
+ More Snippets